Home » Topics » Regulatory » Patents

Patents
RSS

MS therapeutics from Lilly

Aug. 14, 1997

Endothelin antagonists disclosed by SKB

Aug. 14, 1997

Arginine mimetics from Boehringer Mannheim

Aug. 13, 1997

Antiinflammatory drugs in early development at Searle

Aug. 13, 1997

MMP inhibitors described by Agouron

Aug. 13, 1997

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

MMP/TNF-alpha inhibitors from Novartis

Aug. 12, 1997

Orally active PDE IV inhibitors from Merck Frosst

Aug. 11, 1997

Oral carbapenem antibacterial agents from Lederle (Japan)

Aug. 11, 1997

Cephalon reports cysteine/serine protease inhibitors with broad therapeutic potential

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...